Φορτώνει......
Immunotherapy for malignant pleural mesothelioma: current status and future directions
Malignant pleural mesothelioma (MPM) has been marked historically by poor prognosis. Current standard of care for this deadly disease results in sub-optimal improvements in overall survival (OS), which has prompted researchers to explore innovative treatment alternatives. Immunotherapy is an emergin...
Αποθηκεύτηκε σε:
Τόπος έκδοσης: | Transl Lung Cancer Res |
---|---|
Κύριοι συγγραφείς: | , , |
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
AME Publishing Company
2017
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5504119/ https://ncbi.nlm.nih.gov/pubmed/28713676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2017.05.02 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|